PDF

Bullous Lung disease

Gilbert Berdine MDa, Nopakoon Nantsupawat MDb

Correspondence to Gilbert Berdine MD.
Email: gilbert.berdine@ttuhsc.edu

+ Author Affiliation - Author Affiliation
a a pulmonary physician in the Department of Internal Medicine, Texas Tech University Health Science Center in Lubbock, TX.
ba research assistant in the Department of Internal Medicine at TTUHSC in Lubbock, TX

SWRCCC : 2013;1.(2):28-29
doi: 10.12746/swrccc2013.0102.020

...................................................................................................................................................................................................................................................................................................................................

A 52-year-old man was referred to Pulmonary Clinic for management of COPD. The patient has noted increasing dyspnea on exertion for the past 6-12 months. Approximately 6 months ago he passed out and was taken to the Emergency Room where he was given a diagnosis of COPD. He currently takes Symbicort, Atrovent, and albuterol. He noted no benefit from Symbicort, limited benefit from albuterol, and major improvement with Atrovent. He smokes 1 pack of cigarettes per day. He tried Chantix without success at smoking cessation. On physical exam he had no acute distress. The patient has distant breath sounds and there are no wheezes. Pulmonary function from 6 months ago included a FVC of 2.83 liters (55%), a FEV1 of 1.47 liters (35%), a FEV1/FVC of 0.518, and no significant improvement following inhaled bronchodilator. TLC was 113% of predicted and RV was 222% of predicted. Diffusion capacity was 47% of predicted with only partial correction for alveolar volume (DL/VA = 66%). CT scan in the ER was negative for pulmonary embolism. Both CT and plain CXR demonstrate large bullae in both lungs with the right lung being much worse than the left (Figures 1 and 2). Based on these images, a V/Q scan was ordered to consider the patient for possible lung volume reduction surgery.



Figure 1

Figure 2

Figure 1and 2 CXR and CT chest demonstrating large bullae in both lungs



Comment

Bullae can develop in emphysematous lungs. Although bullae connect with the bronchial tree, air becomes trapped during the expiration and the bullae increase in size. Together with the losing of elastic recoil of the adjacent lung originates the lung to retract and makes the bullae enlarge.(I am not sure about this sentence .Please review) Cigarette smoking is associated with bullae in lungs; they also develop in other conditions, such as 1-antitrypsin deficiency and pulmonary sarcoidosis. Surgical management should be considered when the patients have respiratory distress with large bullae which occupy more than 30% of the hemithorax and compress the normal surrounding lung tissue. Surgical management is also needed when these patients have lung complications, such as infection or pneumothorax.



Figure 4

Figure 3 V/Q Scan: Perfusion



Figure 4

Figure 4 V/Q Scan: Ventilation



References

  1. Greenberg JA, Singhal S, Kaiser LR. Giant bullous lung disease: evaluation, selection, techniques, and outcomes. Chest Surg Clin N Am 2003; 13:631-49.
  2. De Giacomo T, Rendina EA, Venuta F, et al. Bullectomy is comparable to lung volume reduction in patients with end-stage emphysema. Eur J Cardiothorac Surg 2002; 22:357-62.
  3. Snider GL. Reduction pneumoplasty for giant bullous emphysema. Implications for surgical treatment of nonbullous emphysema. Chest 1996; 109:540-8.
  4. Zar HJ, Cole RP. Bullous emphysema occurring in pulmonary sarcoidosis. Respiration 1995;62:290-3
  5. Kinnear WJM, Tattersfield A. Emphysematous bullae: surgery is best for large bullae and moderately impaired lung function. BMJ1990;300:208-9

...................................................................................................................................................................................................................................................................................................................................


Received: 03/19/2013
Accepted: 03/25/2013
Reviewers: Kenneth Nugent MD
Published electronically: 04/15/2013
Conflict of Interest Disclosures: none

 

Return to top